Video of The Role of PARP Inhibitors in Prostate Cancer
Christopher E. Barbieri, M.D., Ph.D., surgeon and researcher in prostate cancer, talks to Targeted Oncology about the role of PARP inhibitors in castration-resistant prostate cancer.
Meyer members among Damon Runyon awardees
From ‘tache to test: Movember Foundation funds research into non-invasive blood test for metastatic prostate cancer
Leading researchers recommend major change in prostate cancer treatment
Molecular link discovered between prostate and breast cancer, suggesting new treatment approach for men's tumor
New study sheds light on prostate cancer development
Most commonly used treatment for prostate cancer is radiotherapy
Prostate cancer screening guidelines called into question
Device registry required to determine efficacy of newest prostate cancer treatment
Wealthy white men more likely to get robotic surgery
Already too late to stop costly radiotherapy and surgery technologies?
Active surveillance may be underused for men with localized prostate cancer